TORONTO, ON / ACCESSWIRE / February 28, 2017 / Bison Gold Resources Inc. (TSXV: BGE) (the “Company”) announces that on or about February 17, 2017, the Company and its directors were served with an application in the Manitoba Court of Queen’s Bench by a minority shareholder of the Company. The applicant complains of the Company’s decision to complete its non-brokered private placement, which closed in two tranches on November 21, 2016 and January 12, 2017 and which raised funds for the Company totalling $950,000. The applicant seeks, among other relief, the removal of the incumbent directors and the CEO and CFO of the Company. The Company and the directors believe the application to be without merit. The application is currently scheduled to be heard on April 28, 2017 in Winnipeg.

For further information, please contact:

Amir Mousavi, Chief Executive Officer
Bison Gold Resources Inc.
Tel: (647) 846-3339
www.bisongold.com

Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

This news release contains certain “forward-looking information” within the meaning of applicable securities law. Forward looking information is frequently characterized by words such as “plan”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “would”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Forward-looking information is based on the opinions and estimates of management at the date the information is provided, and is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change, unless required by law. The reader is cautioned not to place undue reliance on forward-looking information.

Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.

SOURCE: Bison Gold Resources Inc.

ReleaseID: 456200

MORRISVILLE, NC / ACCESSWIRE / February 28, 2017 / Issuer Direct Corporation (NYSE MKT: ISDR), an industry-leading communications and compliance company today announced that its Founder and Chief Executive Officer, Brian R. Balbirnie will present at the 29th Annual Roth Conference at 11:30 a.m. (PT) on Wednesday, March 15, 2017 and will conduct one-on-one meetings that day.

The conference will be held March 12-15, 2017 at The Ritz Carlton, located at 1 Ritz Carlton Drive in Dana Point, Calif. and is by invitation only. For more information, please contact conference@roth.com or your ROTH representative at (800) 933-6830.

About the 29th Annual ROTH Conference:

This conference is one of the largest of its kind in the U.S. Following the success of previous years’ events, the ROTH Conference, with close to 500 participating companies and over 4,000 attendees, will feature presentations from hundreds of public and private companies in a variety of sectors including Healthcare Technology, Internet & Media, Cleantech, Industrial Growth & Solar, Consumer, Oil & Gas / Mining & Minerals and Business Services. ROTH combines company presentations, one-on-one and small group meetings and panel discussions.

About Issuer Direct Corporation:

Issuer Direct® is an industry-leading communications and compliance company focusing on the needs of corporate issuers. Issuer Direct’s principal platform, Platform id, empowers users by thoughtfully integrating the most relevant tools, technologies and services, thus eliminating the complexity associated with producing and distributing financial and business communications. Headquartered in RTP, NC, Issuer Direct serves more than 2,000 public and private companies in more than 18 countries. For more information, please visit www.issuerdirect.com.

For Further Information:

Issuer Direct Corporation
Brian R. Balbirnie
919-481-4000
brian.balbirnie@issuerdirect.com

Brett Maas
Hayden IR
(646) 536-7331
brett@haydenir.com

James Carbonara
Hayden IR
(646)-755-7412
james@haydenir.com

SOURCE: Issuer Direct Corporation

ReleaseID: 456127

NEW YORK, NY / ACCESSWIRE / February 28, 2017 /
U.S. markets rose across the board Monday, with the Dow Jones closing at a new all-time high for the 12th consecutive session as investors eagerly await President Donald Trump’s speech to Congress Tuesday, which is expected to provide some details on tax cuts and an overhaul of the health-care system. The Dow Jones Industrial Average gained 0.08 percent to close at 20,837.44, up 5.44 percent year-to-date, while the S&P 500 Index gained 0.1 percent to close at 2,369.75, up 5.85 percent year-to-date.

Register today for a
free membership and gain access to daily research reports at: RDInvesting.com

“People are ultimately focused on what kind of tone President Trump will strike during his speech on Tuesday,” said Ian Winer, director of equity trading at Wedbush Securities. “The biggest risk to stocks would be a speech that is nationalistic and protectionist, something markets do not like,” Winer said.

“What I’m watching out for is whether his focus is on the pro-growth policies or on the populist message,” said Dan Miller, director of equities at GW&K Investment Management.

Let’s Take a
Closer Look at Today’s Trending Tickers

Micron Technology’s shares gained 2.24 percent to close at $23.76 a share on Monday. The stock traded between $23.15 and $23.77 on volume of 18.00 million shares traded. Baird analyst Tristan Gerra has recently raised the company’s price target to $35 from $25 and has maintained an “outperform” rating on the stock. Consensus rating on the company’s stock is “outperform”. Micron Technology is scheduled to release results for the second quarter of fiscal 2017 after market close on Thursday, March 23rd. Shares of Micron Technology have gained approximately 8.4 percent year-to-date.

“Supply/demand outlook for both DRAM and NAND remain positive for 2017. Micron’s execution in the ramp of 18nm DRAM is much improved from prior nodes, in our view. Concerns about a 2H17 peak in NAND supply/demand trends are unwarranted, in our view, and we expect tightness throughout the year, notably as 2D capacity needs to be decommissioned in order for 3D capacity to ramp,” commented Gerra.

Access Today’s Micron Technology Research
Report Click Here

ImmunoGen’s shares soared 21.03 percent to close at $3.28 a share on Monday. The stock traded between $2.74 and $3.34 on volume 7.75 million shares traded. The company has previously disclosed that effective January 1, 2017, it has transitioned to a fiscal year ending December 31. Revenues for the six-month transition period ended December 31, 2016 were $21.5 million, compared to $32.9 million for the six months ended December 31, 2015. For the year 2017, the company expects revenues in the range of $70 million to $75 million, including $28 million of expected upfront and milestone fees from their partners. ImmunoGen recently presented at the 2017 RBC Capital Markets Global Healthcare Conference on February 23rd and is scheduled to present at the Cowen and Company 37th Annual Health Care Conference on March 7th, 2017 at 8:40 am ET. Shares of ImmunoGen have gained approximately 60.8 percent year-to-date.

Access Today’s ImmunoGen Research Report
Click Here

Today’s Features Includes:

Micron Technology, Inc. (NASDAQ: MU)

ImmunoGen, Inc. (NASDAQ: IMGN)

Research Driven
Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Hemal K. Gandhi, a CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information, please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 456174

NEW YORK, NY / ACCESSWIRE / February 28, 2017 /
U.S. markets rose across the board Monday, with the Dow Jones closing at a new all-time high for the 12th consecutive session as investors eagerly await President Donald Trump’s speech to Congress Tuesday, which is expected to provide some details on tax cuts and an overhaul of the health-care system. The Dow Jones Industrial Average gained 0.08 percent to close at 20,837.44, up 5.44 percent year-to-date, while the S&P 500 Index gained 0.1 percent to close at 2,369.75, up 5.85 percent year-to-date.

Register today for a
free membership and gain access to daily research reports at: RDInvesting.com

Defense contractors received a boost Monday after President Trump stated that first budget proposal would contain a “historic increase” in defense spending. The Office of Management and Budget had also stated they the budget would look to increase defense spending by $54 billion, approximately a 10 percent increase, which would be offset by cuts in other areas.

Let’s Take a
Closer Look at Today’s Trending Tickers

Boeing’s shares gained 1.12 percent to close at $179.43 a share on Monday. The stock traded between $177.55 and $179.88 on volume of 2.89 million shares traded. On February 22nd, the company announced the delivery of its first 787-9 Dreamliner to Korean Air. “The Boeing 787-9 Dreamliner is the second member of the super-efficient, passenger-pleasing 787 family. Both the 787-8 and 787-9 bring the economics of large jets to the middle of the market, with 20 percent less fuel use and 20 percent fewer emissions than the airplanes they replace,” wrote Boeing in the news release. Shares of Boeing have gained approximately 15.26 percent year-to-date.

Access Today’s Boeing Research Report Click
Here

Lockheed Martin’s shares increased 1.26 percent to close at $269.36 a share on Monday. The stock traded between $264.20 and $270.00 on volume 1.50 million shares traded. On February 23rd, the company announced plans to relocate the Fleet Ballistic Missile (FBM) program within its Space Systems business area to co-locate employees in facilities with common skills and resource requirements. These moves, which are enabled by government approval, are expected to deliver substantial cost savings while centralizing mission expertise in key locations. Shares of Lockheed Martin have gained approximately 7.77 percent year-to-date.

“We value the deep expertise of our employees, and we’re working diligently to shape a transition that leverages the knowledge of this team,” said Rick Ambrose, Executive Vice President, Lockheed Martin Space Systems. “Reshaping our Fleet Ballistic Missile program will help us take full advantage of our engineering and manufacturing facilities and centralize key skills, saving costs for the Navy on this critical national security program.”

Access Today’s Lockheed Martin Research
Report Click Here

Today’s Features Includes:

Boeing Co. (NYSE: BA)

Lockheed Martin Corporation (NYSE: LMT)

Research Driven
Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Hemal K. Gandhi, a CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information, please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 456173

VANCOUVER, BC / ACCESSWIRE / February 28, 2017 / One World Minerals Inc. (CSE: OWM) (the “Company”) announces its listing on the Canadian Securities Exchange at market open today under the trading symbol OWM and its name change from “One World Investments Inc.” to “One World Minerals Inc.”

The Company is also pleased to announce that, effective on listing, the Company was assigned all rights and obligations from Stand Up Investments Ltd., a private British Columbia company (“Stand Up”), under an Option Agreement dated December 22, 2015 between Stand Up and a third party (the “Option Agreement”). The Option Agreement grants Stand Up an option (the “Option”) to acquire a 100% interest in the Mogollon silver-gold project (the “Property”) by paying an aggregate of US$750,000 in staged annual payments to the third party optionor over a three year period. In consideration for the assignment of the Option by Stand Up, the Company: (i) paid Cdn$100,000 and issued 5 million shares, (ii) is required to pay Cdn$200,000 and issue 5 million shares on April 01, 2018, (iii) is required to issue 5 million shares on April 01, 2019, and (iv) is required to grant Stand Up a 1% new smelter return royalty with respect to the Property, payable upon commencement of commercial production. The initial 5 million shares are subject to a hold period expiring July 1, 2017.

The Property is located in Catron County, New Mexico, United States and consists of 64 unpatented and 81 patented lode mining claims that are prospective for gold and silver. Certain portions of the Property are subject to an existing net smelter return royalty.

Additionally, the Company settled debt in the aggregate amount of Cdn$1,618,837 with creditors of the Company through the issuance of an aggregate amount of 32,376,737 common shares at a deemed price of Cdn$0.05 per share. The shares are subject to a hold period and will be released 25% starting July 1, 2017 and then thereafter every three months and one day with the last hold period expiring on March 1, 2018.

As well, the Company is also pleased to announce that it has closed its previously announced non-brokered private placement of convertible debentures in the principal amount of Cdn$516,457 which were converted into 10,329,140 common shares at a conversion price of $0.05 per common share. The shares are subject to a hold period and will be released 25% starting on July 1, 2017 and then thereafter every three months and one day with the last hold period expiring on March 1, 2018.

On behalf of the Board of Directors of One World Minerals Inc.

Doug Fulcher, CEO and President

“Doug Fulcher”

For additional information, contact:

Doug Fulcher, CEO and President
Direct: 604.803.5901

SOURCE: One World Minerals Inc.

ReleaseID: 456196

NEW YORK, NY / ACCESSWIRE / February 28, 2017 / U.S. markets rose across the board Monday, with the Dow Jones closing at a new all-time high for the 12th consecutive session as investors eagerly await President Donald Trump’s speech to Congress Tuesday, which is expected to provide some details on tax cuts and an overhaul of the health-care system. The Dow Jones Industrial Average gained 0.08 percent to close at 20,837.44, up 5.44 percent year-to-date, while the S&P 500 Index gained 0.1 percent to close at 2,369.75, up 5.85 percent year-to-date.

Register today for a
free membership and gain access to daily research reports at: RDInvesting.com

“People are ultimately focused on what kind of tone President Trump will strike during his speech on Tuesday,” said Ian Winer, director of equity trading at Wedbush Securities. “The biggest risk to stocks would be a speech that is nationalistic and protectionist, something markets do not like,” Winer said.

“What I’m watching out for is whether his focus is on the pro-growth policies or on the populist message,” said Dan Miller, director of equities at GW&K Investment Management.

Let’s Take a
Closer Look at Today’s Trending Tickers

Tesla’s shares dropped 4.19 percent to close at $246.23 a share on Monday. The stock traded between $242.01 and $248.36 on volume of 11.46 million shares traded. Shares of the company dipped after Goldman Sachs downgraded the company’s rating to “sell” from “neutral” as they expect the launch of Tesla’s Model 3 to be delayed and expects that the company will have to sell stocks worth $1.7 billion to meet its capital spending plans. Goldman also trimmed six month target price for the company from $190 to $185. Consensus rating on the company’s stock is “hold”. Shares of Tesla have gained approximately 15.2 percent year-to-date.

“While we believe Tesla currently has a lead relative to OEM (original equipment manufacturer) peers with respect to vehicle technology adoption, electric vehicle architecture, and (potentially) battery scale, our concerns are more near-term oriented with respect to operational execution on the Model 3 launch, an unproven solar business, and cash needs,” wrote Goldman Sachs’ analysts led by David Tamberrino in a note.

Access Today’s Tesla Research Report Click
Here

NVIDIA’s shares gained 2.91 percent to close at $104.41 a share on Monday. The stock traded between $101.56 and $105.02 on volume 17.89 million shares traded. Goldman Sachs has maintained a “conviction buy” rating on the company with a price target of $130. Consensus rating on the company’s stock is “outperform”. Shares of NVIDIA have fallen approximately 2.18 percent year-to-date, but have gained nearly 230 percent in the past year.

“While we recognize the slight cut to EPS by the Street post F4Q EPS (in our view primarily due to higher opex and share count), bottom line, we see this as an opportunity to add to positions (or to initiate positions for those who missed the rally in 2016). Most importantly, we believe the multiyear secular growth story in Gaming, Data Center and Automotive remains intact. We are positioned above the Street (+20%/+50% on CY17/18 EPS) and would expect a scenario similar to last year (i.e. positive estimate revisions –> stock price outperformance) to play out over the coming quarters and reiterate our CL-Buy with 28% potential upside to our 12-month price target of $130. In this report, we highlight where/how we differ from the Street and address client pushback,” wrote Goldman Sachs analyst Toshiya Hari in a note to clients.

Access Today’s NVIDIA Research Report Click
Here

Today’s Features Includes:

Tesla Inc. (NASDAQ: TSLA)

NVIDIA Corporation (NASDAQ: NVDA)

Research Driven
Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Hemal K. Gandhi, a CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information, please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 456171

The Extel Survey, Europe’s Largest and Most Comprehensive Evaluation of Buy-Side, Sell-Side and IR Teams, will Launch on 22nd March 2017;
WeConvene Extel is Pleased to Announce that Experienced Sell-Side Professional, David Enticknap, Joins as MD of Extel

LONDON, UNITED KINGDOM / ACCESSWIRE / February 28, 2017 / The Extel Survey, Europe’s leading independent evaluation of Buy-Side, Sell-Side and IR interactions, launches on 22nd March 2017, with results being announced on 7th June 2017. In 2016, the survey garnered over 1,000,000 votes from 10,000 Buy-Side participants, 3,000 Sell-Side participants, and 1,400 corporates, making it the largest and most thorough evaluation of services and interactions between investment professionals.

Newly appointed MD of Extel, David Enticknap, said, “This year’s Extel survey is more relevant than ever as firms evolve to adhere to meet the regulatory requirements of MiFID II. It’s the most comprehensive public and independent evaluation of interactions between the investment community.” He further stated, “I am excited to be taking the Extel Survey into the future during a time of great change for our clients.”

WeConvene CEO, Radek Barnert, commented, “We are excited to have David join the WeConvene Extel team and bring with him extensive sell-side experience, which will only help to enhance the Extel product suite for our clients as they prepare for MiFID II.”

The key dates for the 2017 Extel Survey are:

Voting Opens: 22nd March 2017
Registration and voting at: www.extelsurveys.com
Voting Closes: 28th April 2017
Results will be published: 7th June 2017

About WeConvene:

WeConvene is a global and truly independent web based platform that automates corporate access consumption and evaluation for the buy-side and sell-side. Extel, 100% owned by WeConvene, is the largest independent survey of buy-side, sell-side and IR teams. For more information, visit www.weconvene.com, or
www.extelsurveys.com.

CONTACT:

Sarah Linfoot
sarah@weconvene.com

SOURCE: WeConvene Limited

ReleaseID: 455247

NEW YORK, NY / ACCESSWIRE / February 28, 2017 /
U.S. markets rose across the board Monday, with the Dow Jones closing at a new all-time high for the 12th consecutive session as investors eagerly await President Donald Trump’s speech to Congress Tuesday, which is expected to provide some details on tax cuts and an overhaul of the health-care system. The Dow Jones Industrial Average gained 0.08 percent to close at 20,837.44, up 5.44 percent year-to-date, while the S&P 500 Index gained 0.1 percent to close at 2,369.75, up 5.85 percent year-to-date.

Register today for a
free membership and gain access to daily research reports at: RDInvesting.com

“People are ultimately focused on what kind of tone President Trump will strike during his speech on Tuesday,” said Ian Winer, director of equity trading at Wedbush Securities. “The biggest risk to stocks would be a speech that is nationalistic and protectionist, something markets do not like,” Winer said.

“What I’m watching out for is whether his focus is on the pro-growth policies or on the populist message,” said Dan Miller, director of equities at GW&K Investment Management.

Let’s Take a
Closer Look at Today’s Trending Tickers

La Jolla Pharmaceutical’s shares soared 76.75 percent to close at $35.12 a share on Monday. The stock traded between $28.20 and $37.67 on volume of 18.30 million shares traded. The company reported that its LJPC-501 (angiotensin II) drug, a treatment for catecholamine resistant hypotension, achieved its primary objective in a recent late stage study. Shares of La Jolla Pharmaceutical have gained approximately 100 percent year-to-date.

“These study results support that angiotensin II, a molecule first synthesized by Dr. Irvine Page at the Cleveland Clinic, improves outcomes in distributive shock patients requiring high-dose catecholamines. Given the high mortality from this condition, it is important to offer physicians another potential treatment option,” said Daniel Sessler, M.D., the Michael Cudahy Professor and Chair of the Department of Outcomes Research at Cleveland Clinic.

Access Today’s La Jolla Pharmaceutical
Research Report Click Here

Advanced Micro Devices’ shares spiked 7.65 percent to close at $15.20 a share on Monday. The stock traded between $14.27 and $15.35 on volume 95.42 million shares traded. The company has received a lot of attention since releasing their new Ryzen central processing units last week. The Ryzen CPU promises to outperform competitor Intel’s CPUs at a fraction of the cost. AMD is scheduled to present at the 2017 Game Developers Conference in San Francisco on Feb. 28 at 10:30 a.m. PT. Shares of Advanced Micro Devices have gained approximately 34.0 percent year-to-date.

Access Today’s Advanced Micro Devices
Research Report Click Here

Today’s Features Includes:

La Jolla Pharmaceutical Company (NASDAQ: LJPC)

Advanced Micro Devices, Inc. (NASDAQ: AMD)

Research Driven
Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Hemal K. Gandhi, a CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information, please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 456172